Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models-Reference-Cited by-同舟云学术

Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models

Published:2017-12 Issue:1 Volume:17 Page:
ISSN:1471-2288
Container-title:BMC Medical Research Methodology
language:en
Short-container-title:BMC Med Res Methodol

Author:

Degeling Koen^ORCID,IJzerman Maarten J.,Koopman Miriam,Koffijberg Hendrik

Publisher

Springer Science and Business Media LLC

Subject

Health Informatics,Epidemiology

Link

http://link.springer.com/content/pdf/10.1186/s12874-017-0437-y.pdf

Reference29 articles.

1. Barbieri CE, Chinnaiyan AM, Lerner SP, Swanton C, Rubin MA. The emergence of precision urologic oncology: a collaborative review on biomarker-driven therapeutics. Eur Urol. 2017;71(2):237–46.

2. Annemans L, Redekop K, Payne K. Current methodological issues in the economic assessment of personalized medicine. Value Health. 2013;16(6 Suppl):S20–6.

3. Degeling K, Koffijberg H, IJzerman MJ. A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models. Expert Rev Pharmacoecon Outcomes Res. 2017;17(1):17–25.

4. Briggs AH, Weinstein MC, Fenwick EAL, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group–6. Med Decis Mak. 2012;32(5):722–32.

5. Nixon RM, Wonderling D, Grieve RD. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared. Health Econ. 2010;19(3):316–33.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Utility Analysis of Rosuvastatin (20 mg) to Prevent Cardiovascular Diseases in Iran;Advanced Biomedical Research;2024-06

2. Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review;PharmacoEconomics;2023-06-23

3. Modeling methods and the degree of parameter uncertainty in probabilistic analyses of economic evaluations;Network Modeling Analysis in Health Informatics and Bioinformatics;2022-12-28

4. Economic evaluation of using polygenic risk score to guide risk screening and interventions for the prevention of type 2 diabetes in individuals with high overall baseline risk;Frontiers in Genetics;2022-09-15

5. A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials;Expert Review of Pharmacoeconomics & Outcomes Research;2022-08-19